The early diagnosis of tuberculosis with novel non-sputum-based biomarkers is of high priority in End TB strategy. MicroRNAs are significant regulators of TB pathogenesis and their differential expression pattern among healthy, latent, and active TB population has revealed their potentiality as biomarkers in recent studies. We performed systematic review and meta-analysis on the role of host miRNAs in TB diagnosis. PubMed, Ovid, and Cochrane databases were searched to retrieve published literature. Relevant studies were screened, and their quality was assessed using STARD guidelines and QUADAS-2 tool. Heterogeneity of studies and overall pooled results of sensitivity, specificity, and DOR were determined by forest plots. Out of 447 studies, 21 were included for qualitative analysis and eight for meta-analysis. Among these, miR-31 had the maximum diagnostic accuracy, with a sensitivity of 96% (89·7-98·5), specificity of 89% (81·2-93·8), and DOR of 345·9 (90·2-1326·3), meeting the minimal target product profile (TPP) for TB diagnostics. Funding Information: This work was supported by the Department of Science and Technology (DST), DST-INSPIRE fellowship. Declaration of Interests: The authors declare no conflicts of interest.